DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epirubicin (Epirubicin) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (40)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 40   Next >>

Possible Epirubicin side effects in male

Reported by a physician from United Kingdom on 2012-08-23

Patient: male, weighing 82.0 kg (180.4 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: most recent dose: 02/may/2012; most recent dose: 96 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21

Xeloda
    Dosage: most recent dose: 09/may/2012 and most recent dose: 2500 mg daily
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2012-03-21

Cisplatin
    Dosage: most recent dose: 02/may/2012; most recent dose: 110 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21

Avastin
    Dosage: most recent dose: 02/may/2012; most recent dose: 577 mg
    Indication: Gastric Cancer
    Start date: 2012-03-21



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-08-16

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-08-09

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Trastuzumab
    Dosage: form:vial

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04



Possible Epirubicin side effects in male

Reported by a physician from Poland on 2012-07-24

Patient: male, weighing 77.0 kg (169.4 pounds)

Reactions: Dyspnoea, Pleural Effusion, Palmar-Plantar Erythrodysaesthesia Syndrome, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06

Capecitabine
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06

Oxaliplatin
    Indication: Metastatic Gastric Cancer
    Start date: 2010-10-27
    End date: 2011-04-06



Possible Epirubicin side effects in 58 year old female

Reported by a physician from Taiwan, Province of China on 2012-07-24

Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)

Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Start date: 2010-12-28
    End date: 2010-12-28

Taxotere
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Taxotere
    Start date: 2010-12-28
    End date: 2010-12-28

Epirubicin
    Indication: Breast Cancer
    Start date: 2010-09-30
    End date: 2010-09-30

Other drugs received by patient: Granocyte



Possible Epirubicin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)

Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Epirubicin
    Dosage: 7 cycles, total 4 courses
    Indication: Breast Cancer
    Start date: 2011-07-22
    End date: 2011-09-22

Taxotere
    Dosage: 4 cycles, total 3 courses, dose taken once daily
    Indication: Breast Cancer
    Start date: 2011-10-14
    End date: 2011-11-25

Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S



Possible Epirubicin side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-02

Patient: 50 year old female

Reactions: Acute Myeloid Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: received eight courses.

Therapeutic Radiopharmaceuticals
    Dosage: received 50 gy of irradiation to conserved breast and supraclavicular fossa

Cyclophosphamide
    Dosage: received eight courses.

Docetaxel
    Dosage: eight courses.



Possible Epirubicin side effects in 63 year old male

Reported by a physician from Poland on 2012-06-27

Patient: 63 year old male

Reactions: Dyspnoea, Palmar-Plantar Erythrodysaesthesia Syndrome, Pleural Effusion, General Physical Health Deterioration, Neutropenia, Polyneuropathy, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Indication: Product Used FOR Unknown Indication

Capecitabine
    Indication: Product Used FOR Unknown Indication

Epirubicin
    Indication: Product Used FOR Unknown Indication



Possible Epirubicin side effects in 68 year old female

Reported by a physician from Japan on 2012-06-15

Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

Epirubicin
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15

Patient: female

Reactions: Breast Cancer, Maternal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2007-01-01
    End date: 2007-01-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-01-01
    End date: 2007-01-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2007-01-01
    End date: 2007-01-01



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-06-01

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-31

Patient: 49 year old female

Reactions: Multi-Organ Failure, Acute Lymphocytic Leukaemia, Pneumonia, Dizziness, Pancytopenia, Septic Shock, Asthenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II

Cyclophosphamide
    Indication: Breast Cancer Stage II

Prednisolone

Other drugs received by patient: Cytarabine; Vincristine; Doxorubicin HCL; Dexamethasone; Methotrexate



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30

Patient: 49 year old female

Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Dosage: 100 mg
    Administration route: Oral
    Indication: Anaemia

Prednisolone
    Indication: Leukocytosis

Fluorouracil
    Indication: Breast Cancer

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Cyclophosphamide
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Leukocytosis
    Start date: 2009-07-01

Epirubicin
    Indication: Breast Cancer

Prednisolone
    Dosage: 15 mg
    Indication: Anaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia



Possible Epirubicin side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-29

Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Gastrointestinal Anastomotic Leak, Respiratory Disorder, Atrial Fibrillation, Diaphragmatic Hernia, Post Procedural Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Start date: 2011-11-17

Capecitabine
    Administration route: Oral
    Start date: 2011-12-08

Cisplatin
    Start date: 2011-11-17

Cisplatin
    Indication: Gastric Cancer
    Start date: 2011-09-22

Epirubicin
    Start date: 2011-11-17

Capecitabine
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Indication: Gastric Cancer
    Start date: 2011-09-22



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-28

Patient: 49 year old female

Reactions: Pneumonia, B Precursor Type Acute Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer

Cytarabine
    Indication: Breast Cancer

Vincristine
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer

Doxorubicin HCL
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Methotrexate
    Indication: Breast Cancer

Dexamethasone
    Indication: Breast Cancer



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-25

Patient: 49 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II

Epirubicin
    Indication: Breast Cancer Stage II



Possible Epirubicin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-25

Patient: female

Reactions: Sudden Cardiac Death, Cardiac Failure Congestive

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer

Paclitaxel

Fluorouracil
    Indication: Breast Cancer

Trastuzumab

Trastuzumab
    Indication: Breast Cancer



Possible Epirubicin side effects in 35 year old male

Reported by a individual with unspecified qualification from Norway on 2012-05-24

Patient: 35 year old male

Reactions: Neoplasm Malignant, Drug Ineffective

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Indication: Oesophageal Adenocarcinoma

Epirubicin
    Indication: Oesophageal Adenocarcinoma

Oxaliplatin
    Indication: Oesophageal Adenocarcinoma



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23

Patient: female

Reactions: Cardiac Failure Congestive

Adverse event resulted in: death

Drug(s) suspected as cause:
Fluorouracil
    Dosage: dose unit:500
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Trastuzumab

Trastuzumab
    Indication: Breast Cancer

Epirubicin
    Dosage: dose unit:75
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: dose unit:500
    Indication: Breast Cancer



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-22

Patient: 49 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer Stage II

Cytoxan
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytoxan
    Dosage: 100 mg, unk
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 67 year old male

Reported by a consumer/non-health professional from United Kingdom on 2012-05-18

Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Gastrointestinal Anastomotic Leak, Post Procedural Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Capecitabine
    Dosage: 5250 mg, unk
    Administration route: Oral
    Start date: 2011-12-08

Cisplatin
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Dosage: 655 mg, unk
    Start date: 2011-11-17

Capecitabine
    Dosage: unk
    Administration route: Oral
    Indication: Gastric Cancer
    Start date: 2011-09-22

Cisplatin
    Dosage: 120 mg, unk
    Start date: 2011-11-17

Epirubicin
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Bevacizumab
    Dosage: unk
    Indication: Gastric Cancer
    Start date: 2011-09-22

Epirubicin
    Dosage: 50 mg, unk
    Start date: 2011-11-17



Possible Epirubicin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient: female

Reactions: B-Cell Lymphoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: B-Cell Lymphoma
    Start date: 2010-05-11

Rituxan
    Indication: B-Cell Lymphoma
    Start date: 2010-05-11

Cytoxan
    Indication: B-Cell Lymphoma
    Start date: 2010-05-11



Possible Epirubicin side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15

Patient: 49 year old female

Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Fluorouracil
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01

Epirubicin
    Indication: Breast Cancer Stage II
    Start date: 2008-03-01



Possible Epirubicin side effects in 68 year old female

Reported by a physician from Japan on 2012-05-04

Patient: 68 year old female, weighing 39.9 kg (87.8 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Nausea, Hypotension, Tachycardia, Toxic Epidermal Necrolysis, Pyrexia, Haemoglobin Decreased, Respiratory Failure, Circulatory Collapse, Neutropenia, Rash Vesicular, Oxygen Saturation Decreased, Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2012-02-28
    End date: 2012-02-28



Possible Epirubicin side effects in 48 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-26

Patient: 48 year old female

Reactions: Respiratory Failure, Pneumothorax, Pulmonary Fibrosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Breast Cancer



Possible Epirubicin side effects in female

Reported by a physician from Finland on 2012-04-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Epirubicin
    Dosage: on day 1
    Indication: Breast Cancer

Docetaxel
    Dosage: on day 1 as 1-hr intravenous infusion
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: on day 1
    Indication: Breast Cancer

Fluorouracil
    Dosage: on day 1
    Indication: Breast Cancer

Other drugs received by patient: Corticosteroids



Possible Epirubicin side effects in female

Reported by a physician from Finland on 2012-04-23

Patient: female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Breast Cancer

Capecitabine
    Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
    Administration route: Oral
    Indication: Breast Cancer

Docetaxel
    Dosage: on day 1 as 1-hr intravenous infusion
    Indication: Breast Cancer

Epirubicin
    Dosage: on day 1
    Indication: Breast Cancer

Capecitabine
    Dosage: first dose administered on day 1 evening and last dose administered on day 15 morning every 3 weeks.
    Administration route: Oral

Other drugs received by patient: Corticosteroids



Possible Epirubicin side effects in 35 year old female

Reported by a physician from Philippines on 2012-04-02

Patient: 35 year old female, weighing 56.2 kg (123.6 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Trastuzumab
    Dosage: form:vialtotal dose recieved:336 mg
    Start date: 2011-07-21

Fluorouracil
    Dosage: form:vial
    Start date: 2010-11-04

Trastuzumab
    Dosage: form:vial

Epirubicin
    Dosage: form:vialtotal dose recieved:140 mg
    Start date: 2010-11-04

Cyclophosphamide
    Dosage: form:vialtotal dose recieved:936 mg
    Start date: 2010-11-04

Docetaxel
    Dosage: form:vialtotal dose recieved:152 mg
    Start date: 2010-09-02



Possible Epirubicin side effects in 50 year old female

Reported by a physician from Mexico on 2012-03-30

Patient: 50 year old female, weighing 65.5 kg (144.1 pounds)

Reactions: Interstitial Lung Disease

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Cyclophosphamide
    Dosage: 3 cycles.

Taxotere
    Start date: 2012-01-18
    End date: 2012-01-18

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Fluorouracil
    Dosage: 3 cycles.

Taxotere
    Start date: 2012-02-09
    End date: 2012-02-09

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Taxotere
    Start date: 2012-03-09
    End date: 2012-03-09

Epirubicin
    Dosage: 3 cycles.



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014